Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexofenadine Monitored Release in Filipino Children
NCT00741897Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2002
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fexofenadine in allergic rhinitis (AR), sponsored by Sanofi. Started Mar 2002; status: completed.
02
Drugs
fexofenadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00741897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00741897.